Related references
Note: Only part of the references are listed.Development of an Interleukin-1β Vaccine in Patients with Type 2 Diabetes
Claudia Cavelti-Weder et al.
MOLECULAR THERAPY (2016)
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Jeff Sevigny et al.
NATURE (2016)
Beyond passive immunization: toward a nanoparticle-based IL-17 vaccine as first in class of future immune treatments
John Foerster et al.
NANOMEDICINE (2015)
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs
Ludger Klimek et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2014)
Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease
Rachelle S. Doody et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms
Hye-Lin Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
A Cucumber Mosaic Virus Based Expression System for the Production of Porcine Circovirus Specific Vaccines
Akos Gellert et al.
PLOS ONE (2012)
The Major Cat Allergen, Fel d 1, in Diagnosis and Therapy
Hans Gronlund et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2010)
The EP3-agonist sulprostone, but not prostaglandin E-2 potentiates platelet aggregation in human blood
Lisa J. Schober et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy
Nicole Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses
Juliana Bessa et al.
JOURNAL OF IMMUNOLOGY (2009)
IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model
Daniel Zagury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Immunodrugs: Therapeutic VLP-Based Vaccines for Chronic Diseases
Gary T. Jennings et al.
Annual Review of Pharmacology and Toxicology (2008)
Coming of age of virus-like particle vaccines
Gary T. Jennings et al.
BIOLOGICAL CHEMISTRY (2008)
Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design
Juliana Bessa et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Effect of immunisation against angiotensin II with CYT006-AngQb on ambulatory blood pressure:: a double-blind, randomised, placebo-controlled phase IIa study
Alain C. Tissot et al.
LANCET (2008)
A vaccine for hypertension based on virus-like particles:: preclinical efficacy and phase I safety and immunogenicity
Patrice M. Ambuehl et al.
JOURNAL OF HYPERTENSION (2007)
Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis
Till A. Roehn et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation
L Goncalves et al.
VIROLOGY (2004)
Identification of an association between HLA class II alleles and low antibody levels after measles immunization
GA Poland et al.
VACCINE (2001)
Share Paper
